HIGHLIGHTS
- who: Eric Tousset et al. from the Division of Nephrology, Department of Medicine, Centre Hospitalier Universitaire Vaudois, du Bugnon, Lausanne, Switzerland have published the research: Clinical Study Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study, in the Journal: (JOURNAL)
- what: The aim of this prospective randomized controlled study was to assess whether an integrated care (IC) approach, in which adherence data are integrated in the decisional process, leads to improved therapeutic control of sHPT and higher percentages of bone metabolism targets . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.